The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Ki67 is a promising molecular target in the diagnosis of cancer (Review)
Open accessAbstract
The expression of Ki67 is strongly associated with tumor cell proliferation and growth, and is widely used in routine pathological investigation as a proliferation marker. The nuclear protein Ki67 (pKi67) is an established prognostic and predictive indicator for the assessment of biopsies from patients with cancer. Clinically, pKi67 has been shown to correlate with metastasis and the clinical stage of tumors. In addition, it has been shown that Ki67 expression is significantly higher malignant tissues with poorly differentiated tumor cells, as compared with normal tissue. According to its predictive role, pKi67 expression identifies subpopulations of patients who are more likely to respond to a given therapy. The Ki67 labeling index is an independent prognostic factor for survival rate, which includes all stages and grade categories. There is a correlation between the ratio of Ki67‑positive malignant cells and patient survival. It has been shown that blocking of Ki67 either by microinjection of antibodies or through the use of antisense oligonucleotides leads to the arrest of cell proliferation. Specifically, antisense oligonucleotides and antibodies against pKi67 have been shown to inhibit the progression of the cell cycle. The Ki67 protein is well characterized at the molecular level and is extensively used as a prognostic and predictive marker for cancer diagnosis and treatment. Increasing evidence indicates that Ki67 may be an effective target in cancer therapy. It therefore merits further development, including testing in more sophisticated in vitro and appropriate in vivo models. This review provides an overview of recent advances in this field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Ki-67 protein: From the known and the unknown
Scholzen, T., & Gerdes, J. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200003)182:3<311::aid-jcp1>3.0.co;2-9 · Cited by 4,646
A System for Stable Expression of Short Interfering RNAs in Mammalian Cells
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,291
Ki67 in breast cancer: prognostic and predictive potential
Yerushalmi, R., Woods, R., Ravdin, P. M., Hayes, M. M., & Gelmon, K. A. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70262-1 · Cited by 1,207
RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells
Yu, J.-Y., DeRuiter, S. L., & Turner, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092143499 · Cited by 1,039
D'Angelo, E., & Prat, J. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.09.023 · Cited by 820
The Gastroenteropancreatic Neuroendocrine Cell System and Its Tumors: The WHO Classification
KLÖPPEL, G., PERREN, A., & HEITZ, P. U. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1294.002 · Cited by 794
Stability of peptide nucleic acids in human serum and cellular extracts
Demidov, V. V., Potaman, V. N., Frank-Kamenetskil, M. D., Egholm, M., Buchard, O., Sönnichsen, S. H., & Nlelsen, P. E. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90171-6 · Cited by 737
A Small Molecule Smac Mimic Potentiates TRAIL- and TNFα-Mediated Cell Death
Li, L., Thomas, R. M., Suzuki, H., De Brabander, J. K., Wang, X., & Harran, P. G. (2004) · Science · doi:10.1126/science.1098231 · Cited by 656
Self-citationInwald, E. C., Klinkhammer-Schalke, M., Hofstädter, F., Zeman, F., Koller, M., Gerstenhauer, M., & Ortmann, O. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2560-8 · Cited by 601
Versatile Photosensitizers for Photodynamic Therapy at Infrared Excitation
Zhang, P., Steelant, W., Kumar, M., & Scholfield, M. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0700707 · Cited by 600
Ki67 protein: the immaculate deception?
Brown, D. C., & Gatter, K. C. (2002) · Histopathology · doi:10.1046/j.1365-2559.2002.01343.x · Cited by 509
Tuominen, V. J., Ruotoistenmäki, S., Viitanen, A., Jumppanen, M., & Isola, J. (2010) · Breast Cancer Research · doi:10.1186/bcr2615 · Cited by 472
ANTISENSE OLIGONUCLEOTIDES: FROM DESIGN TO THERAPEUTIC APPLICATION
Chan, J. H., Lim, S., & Wong, W. F. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2006.04403.x · Cited by 430
Steels, E., Paesmans, M., Berghmans, T., Branle, F., Lemaitre, F., Mascaux, C., Meert, A. P., Vallot, F., Lafitte, J. J., & Sculier, J. P. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.00062201 · Cited by 418
Short hairpin RNA (shRNA): design, delivery, and assessment of gene knockdown
Taxman, D. J., Moore, C. B., Guthrie, E. H., & Huang, M. T.-H. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-657-3_10 · Cited by 365
Prospects of RNA interference therapy for cancer
Pai, S. I., Lin, Y.-Y., Macaes, B., Meneshian, A., Hung, C.-F., & Wu, T.-C. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302694 · Cited by 352
Viale, G., Giobbie-Hurder, A., Regan, M. M., Coates, A. S., Mastropasqua, M. G., Dell'Orto, P., Maiorano, E., MacGrogan, G., Braye, S. G., Öhlschlegel, C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.0829 · Cited by 340
DNA Methylation: An Alternative Pathway to Cancer
Wajed, S. A., Laird, P. W., & DeMeester, T. R. (2001) · Annals of Surgery · doi:10.1097/00000658-200107000-00003 · Cited by 327
Walker, R. A. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02514.x · Cited by 316
Detection of the Ki‐67 antigen in fixed and wax‐embedded sections with the monoclonal antibody MIB1
McCORMICK, D., CHONG, H., HOBBS, C., DATTA, C., & HALL, P. A. (1993) · Histopathology · doi:10.1111/j.1365-2559.1993.tb00135.x · Cited by 294
Martin, B., Paesmans, M., Mascaux, C., Berghmans, T., Lothaire, P., Meert, A.-P., Lafitte, J.-J., & Sculier, J.-P. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602233 · Cited by 277
A Decade of Tissue Microarrays: Progress in the Discovery and Validation of Cancer Biomarkers
Camp, R. L., Neumeister, V., & Rimm, D. L. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.3567 · Cited by 275
Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors
Vaira, V., Fedele, G., Pyne, S., Fasoli, E., Zadra, G., Bailey, D., Snyder, E., Faversani, A., Coggi, G., Flavin, R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907676107 · Cited by 267
Petit, T., Wilt, M., Velten, M., Millon, R., Rodier, J.-F., Borel, C., Mors, R., Haegelé, P., Eber, M., & Ghnassia, J.-P. (2004) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00675-0 · Cited by 264
Starborg, M., Gell, K., Brundell, E., & Höög, C. (1996) · Journal of Cell Science · doi:10.1242/jcs.109.1.143 · Cited by 230
Priorities for Improving the Management of Gastroenteropancreatic Neuroendocrine Tumors
Modlin, I. M., Moss, S. F., Chung, D. C., Jensen, R. T., & Snyderwine, E. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn275 · Cited by 224
Chlebowski, R. T., Col, N., Winer, E. P., Collyar, D. E., Cummings, S. R., Vogel, V. G., Burstein, H. J., Eisen, A., Lipkus, I., & Pfister, D. G. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.06.029 · Cited by 197
Two sides of the coin: affinity and specificity of nucleic acid interactions
Demidov, V. V., & Frank-Kamenetskii, M. D. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.12.007 · Cited by 193
Iatropoulos, M. J., & Williams, G. M. (1996) · Experimental and Toxicologic Pathology · doi:10.1016/s0940-2993(96)80039-x · Cited by 193
Ki-67 expression during rat liver regeneration after partial hepatectomy
Gerlach, C., Sakkab, D. Y., Scholzen, T. E., Daβler, R., Alison, M. R., & Gerdes, J. (1997) · Hepatology · doi:10.1002/hep.510260307 · Cited by 186
RNA expression analysis from formalin fixed paraffin embedded tissues
Farragher, S. M., Tanney, A., Kennedy, R. D., & Paul Harkin, D. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0479-7 · Cited by 184
Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma
Chang, J., Ormerod, M., Powles, T. J., Allred, D. C., Ashley, S. E., & Dowsett, M. (2000) · Cancer · doi:10.1002/1097-0142(20001201)89:11<2145::aid-cncr1>3.0.co;2-s · Cited by 173
Jalava, P., Kuopio, T., Juntti‐Patinen, L., Kotkansalo, T., Kronqvist, P., & Collan, Y. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02402.x · Cited by 169
Blancato, J., Singh, B., Liu, A., Liao, D. J., & Dickson, R. B. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601703 · Cited by 160
Chromophore‐assisted light inactivation of pKi‐67 leads to inhibition of ribosomal RNA synthesis
Rahmanzadeh, R., Hüttmann, G., Gerdes, J., & Scholzen, T. E. (2007) · Cell Proliferation · doi:10.1111/j.1365-2184.2007.00433.x · Cited by 153
Mittempergher, L., de Ronde, J. J., Nieuwland, M., Kerkhoven, R. M., Simón, I., Rutgers, E. J. T., Wessels, L. F. A., & Veer, L. J. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017163 · Cited by 151
The Changing Role of Pathology in Breast Cancer Diagnosis and Treatment
Leong, A. S. ‐., & Zhuang, Z. (2011) · Pathobiology · doi:10.1159/000292644 · Cited by 148
MORIMOTO, R., SATOH, F., MURAKAMI, O., SUZUKI, T., ABE, T., TANEMOTO, M., ABE, M., URUNO, A., ISHIDOYA, S., ARAI, Y., et al. (2008) · Endocrine Journal · doi:10.1507/endocrj.k07-079 · Cited by 141
Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas
Karamitopoulou, E., Perentes, E., Tolnay, M., & Probst, A. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)90224-6 · Cited by 137
Is the Ki-67 labelling index ready for clinical use?
Jonat, W., & Arnold, N. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq732 · Cited by 125
Contemporary Management of Adrenocortical Carcinoma
Zini, L., Porpiglia, F., & Faßnacht, M. (2011) · European Urology · doi:10.1016/j.eururo.2011.07.062 · Cited by 117
Interfering with disease: opportunities and roadblocks to harnessing RNA interference
Lieberman, J., Song, E., Lee, S., & Shankar, P. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00143-6 · Cited by 107
Laurinavičius, A., Plancoulaine, B., Laurinavičienė, A., Herlin, P., Meškauskas, R., Baltrušaitytė, I., Besusparis, J., Dasevičius, D., Elie, N., Iqbal, Y. W., et al. (2014) · Breast Cancer Research · doi:10.1186/bcr3639 · Cited by 107
Molecular Classification of Estrogen Receptor-positive/Luminal Breast Cancers
Geyer, F. C., Rodrigues, D. N., Weigelt, B., & Reis-Filho, J. S. (2011) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e31823fafa0 · Cited by 94
Nielsen, P. S., Riber‐Hansen, R., Jensen, T. Ø., Schmidt, H., & Steiniche, T. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.188 · Cited by 94
Antisense treatment against Ki‐67 mRNA inhibits proliferation and tumor growth in vitro and in vivo
Kausch, I., Lingnau, A., Endl, E., Sellmann, K., DEINERT, I., Ratliff, T. L., Jocham, D., Sczakiel, G., Gerdes, J., & Andreas Böhle, E. (2003) · International Journal of Cancer · doi:10.1002/ijc.11111 · Cited by 88
Konsti, J., Lundin, M., Joensuu, H., Lehtimäki, T., Sihto, H. J., Holli, K., Turpeenniemi-Hujanen, T. M., Kataja, V. V., Sailas, L., Isola, J. J., et al. (2011) · BMC Clinical Pathology · doi:10.1186/1472-6890-11-3 · Cited by 88
Ki67 antigen and PCNA proliferation markers predict survival in anorectal malignant melanoma
Ben‐Izhak, O., Barchana, M., Sussman, L., Dobiner, V., Sandbank, J., Cagnano, M., Cohen, H. I., & Sabo, E. (2002) · Histopathology · doi:10.1046/j.1365-2559.2002.01444.x · Cited by 87
Changing paradigms with molecular imaging of neuroendocrine tumors.
Hofman, M. S., & Hicks, R. J. (2012) · PubMed · Cited by 86
Duchrow, M., Schlüter, C., Wohlenberg, C., Flad, H. D., & Gerdes, J. (1996) · Cell Proliferation · doi:10.1046/j.1365-2184.1996.d01-2.x · Cited by 83
The peptide nucleic acids (PNAs): a new generation of probes for genetic and cytogenetic analyses
Paulasova, P., & Pellestor, F. (2004) · Annales de Génétique · doi:10.1016/j.anngen.2004.07.001 · Cited by 82
Palmqvist, R., Sellberg, P., Öberg, Å., Tavelin, B., Rutegård, M., & Stenling, R. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690091 · Cited by 80
Co‐expression of p53 and Ki67 and lack of EBV expression in oral squamous cell carcinoma
Iamaroon, A., Khemaleelakul, U., Pongsiriwet, S., & Pintong, J. (2003) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2004.00192.x · Cited by 76
Zhu, H., Guo, W., Zhang, L., Davis, J. J., Teraishi, F., Wu, S., Cao, X. X., Daniel, J. M., Smythe, W. R., & Fang, B. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0162 · Cited by 74
Claudio, P. P., Zamparelli, A., Garcia, F. U., Claudio, L., Ammirati, G., Farina, A., Bovicelli, A., Russo, G. M., Giordano, G. G., McGinnis, D. E., et al. (2002) · PubMed · Cited by 71
Hooghe, B., Hulpiau, P., Roy, F. M. V., & Bleser, P. D. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn195 · Cited by 70
Sánchez‐Navarro, I., Gámez‐Pozo, A., González-Barón, M., Pinto-Marín, Á., Hardisson, D., López, R., Madero, R., Cejas, P., Mendiola, M., Espinosa, E., et al. (2010) · BioTechniques · doi:10.2144/000113388 · Cited by 68
Ibrahim, T., Farolfi, A., Scarpi, E., Mercatali, L., Medri, L., Ricci, M., Nanni, O., Serra, L., & Amadori, D. (2012) · Oncology · doi:10.1159/000345795 · Cited by 62
Yoo, S., Gilles, F., Tavare, C., Becker, L., Peter, B., Yates, A., Pollack, I., & Finlay, J. (2006) · Pediatric and Developmental Pathology · doi:10.2350/07-06-0303.1 · Cited by 56
Nielsen, P. S., Riber‐Hansen, R., & Steiniche, T. (2011) · American Journal of Dermatopathology · doi:10.1097/dad.0b013e3182120173 · Cited by 50
Prognostic Impact of Jab1, p16, p21, p62, Ki67 and Skp2 in Soft Tissue Sarcomas
Sørbye, S. W., Kilvaer, T. K., Valkov, A., Dønnem, T., Smeland, E., Al-Shibli, K. I., Bremnes, R. M., & Busund, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047068 · Cited by 50
Zheng, J., Teng-xiang, M., Cao, J., Sun, X., Chen, J., Li, W., Wen, R.-M., Sun, Y., & Pei, D. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.064 · Cited by 46
Self-citationLiu, Y., Jiang, Y., Hao, J., Lu, S.-S., Zhang, T.-T., Shang, L., Cao, J., Song, X., Wang, B., Cai, Y., et al. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.03.001 · Cited by 46
Perera, S. M., Thomas, J. A., Burke, M. M., & Crawford, D. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199802)184:2<130::aid-path19>3.0.co;2-w · Cited by 45
New automated image analysis method for the assessment of Ki-67 labeling index in meningiomas.
Grala, B., Markiewicz, T., Kozłowski, W., Osowski, S., Słodkowska, J., & Papierz, W. (2010) · Folia Histochemica et Cytobiologica · doi:10.2478/v10042-008-0098-0 · Cited by 44
Functional biomarkers in cervical precancer: An overview
Gupta, N., Srinivasan, R., & Rajwanshi, A. (2009) · Diagnostic Cytopathology · doi:10.1002/dc.21270 · Cited by 40
Hsu, C., Ho, D. M., Yang, C., & Chiang, H. (2003) · Modern Pathology · doi:10.1097/01.mp.0000084631.64279.bc · Cited by 39
Nielsen, P. S., Riber‐Hansen, R., Raundahl, J., et al. (2012) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2011-0360-oa · Cited by 34
Klimowicz, A. C., Bose, P., Nakoneshny, S. C., Dean, M. L., Huang, L., Chandarana, S. P., Magliocco, A. M., Matthews, T. W., Brockton, N. T., & Dort, J. C. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.04.010 · Cited by 30
A critical role of Sp1 transcription factor in regulating the human Ki-67 gene expression
Tian, H., Qian, G., Li, W., Chen, F., Di, J., Zhang, B., Pei, D., Ma, P., & Zheng, J. (2010) · Tumor Biology · doi:10.1007/s13277-010-0119-4 · Cited by 30
Self-citationCastro, L. A., Elias, L. S. A., Oton‐Leite, A. F., de Spíndula-Filho, J. V., Leles, C. R., Batista, A. C., & Mendonça, E. F. (2010) · Journal of Oral Science · doi:10.2334/josnusd.52.55 · Cited by 20
Smolina, I., & Demidov, V. V. (2003) · Chemistry & Biology · doi:10.1016/s1074-5521(03)00150-9 · Cited by 18
p53 regulates Ki-67 promoter activity through p53- and Sp1-dependent manner in HeLa cells
Wang, M., Pei, D., Qian, G., Yin, X., Cheng, Q., Li, L., Li, H., & Zheng, J. (2011) · Tumor Biology · doi:10.1007/s13277-011-0191-4 · Cited by 18
Self-citationPanteva, M. T., Salari, R., Bhattacharjee, M., & Chong, L. T. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2011.03.035 · Cited by 16
Place du pathologiste dans la prise en charge néoadjuvante des cancers du sein
Guellec, S. L., Perallon, R., Alunni, J.-P., Charitansky, H., Leaha, C., Gonzalez, A. M., Chateau, M., Simony-Lafontaine, J., Jacot, W., Gutowski, M., et al. (2011) · Annales de Pathologie · doi:10.1016/j.annpat.2011.10.003 · Cited by 9
(2001) · doi:10.1002/1439-7633(20010401)2:4<239::aid-cbic239>3.0.co;2-r
Cited by
Tan, W. C. C., Nerurkar, S. N., Cai, H. Y., Ng, H. H. M., Wu, D., Wee, Y. T. F., Lim, J. C. T., Yeong, J., & Lim, T. K. H. (2020) · Cancer Communications · doi:10.1002/cac2.12023 · Cited by 678
Ki67 targeted strategies for cancer therapy
Yang, C., Zhang, J., Ding, M., Xu, K., Li, L., Mao, L., & Zheng, J. (2018) · Clinical and Translational Oncology · doi:10.1007/s12094-017-1774-3 · Cited by 254
Self-citationThe explainability paradox: Challenges for xAI in digital pathology
Evans, T., Retzlaff, C. O., Geißler, C., Kargl, M., Plass, M., Müller, H., Kiehl, T.-R., Zerbe, N., & Holzinger, A. (2022) · Future Generation Computer Systems · doi:10.1016/j.future.2022.03.009 · Cited by 135
Explainability and causability in digital pathology
Plass, M., Kargl, M., Kiehl, T., Regitnig, P., Geißler, C., Evans, T., Zerbe, N., Carvalho, R., Holzinger, A., & Müller, H. (2023) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.322 · Cited by 99
Jiang, C., Zhang, L., Xu, X., Qi, M., Zhang, J., He, S., Tian, Q., & Song, S. (2021) · Advanced Science · doi:10.1002/advs.202102500 · Cited by 77
Metadata
- Authors
- LI, L. T., JIANG, G., CHEN, Q., & ZHENG, J. N.
- Venue
- Molecular Medicine Reports
- Publisher
- Spandidos Publications
- Published
- 2014-11-10
- Volume
- 11
- Issue
- 3
- Pages
- 1566-1572
- ISSN
- 1791-2997 (ISSN-L)
- 1791-3004
- OpenAlex
- W2093977679
- Cited by
- 859
- References
- 76
- FWCI
- 4.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.